Impact of WIN site inhibitor on the WDR5 interactome

The chromatin-associated protein WDR5 is a promising pharmacological target in cancer, with most drug discovery efforts directed against an arginine-binding cavity in WDR5 called the WIN site. Despite a clear expectation that WIN site inhibitors will alter the repertoire of WDR5 interaction partners...

Descripción completa

Detalles Bibliográficos
Autores principales: Guarnaccia, Alissa D., Rose, Kristie L., Wang, Jing, Zhao, Bin, Popay, Tessa M., Wang, Christina E., Guerrazzi, Kiana, Hill, Salisha, Woodley, Chase M., Hansen, Tyler J., Lorey, Shelly L., Shaw, J. Grace, Payne, William G., Weissmiller, April M., Olejniczak, Edward T., Fesik, Stephen W., Liu, Qi, Tansey, William P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871196/
https://www.ncbi.nlm.nih.gov/pubmed/33472061
http://dx.doi.org/10.1016/j.celrep.2020.108636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871196/
https://www.ncbi.nlm.nih.gov/pubmed/33472061
http://dx.doi.org/10.1016/j.celrep.2020.108636

Ejemplares similares